Evaluating the need for cardiac MRI in patients with premature ventricular complexes
Official title: WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
Run by Centre Hospitalier Universitaire, Amiens · NCT06801743 · Data updated 2026-11-12
This study is trying to see if heart scans are really needed for people with premature ventricular complexes to find any hidden heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Centre Hospitalier Universitaire, Amiens Academic / other |
| Locations | 1 site (Salouël) |
| Status | Recruiting |
| Started | November 27, 2024 |
| Main results expected | November 2025 |
| Study ends | May 2026 |
| Registry record updated | February 13, 2025 |
| Trial ID | NCT06801743 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with PVCs who have already undergone ECG, Holter ECG, and CMR.
✕Probably not a fit
Patients who oppose the use of their personal data for research or those unable to communicate in French may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the necessity of cardiac magnetic resonance imaging (CMR) in patients referred for premature ventricular complexes (PVC) by their cardiologists. PVCs are common and can range from benign to symptomatic, but standard tests may not always detect underlying myocardial abnormalities. The study will include patients who have undergone ECG, Holter monitoring, and CMR to better understand the role of CMR in identifying potential structural heart diseases. The findings could help refine diagnostic approaches for patients experiencing PVCs.
Why it matters
Potential benefit: If successful, this study could improve the diagnostic accuracy for patients with PVCs, leading to better management of underlying heart conditions.
How similar studies have gone: While the use of CMR in assessing cardiac conditions is established, this specific approach to PVCs is less common and may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with PVC who have performed ECG, Holter ECG and a CMR Exclusion Criteria: * patient showing opposition tu use his personal data for the reseach, * patient unable to express his opposition, * patient deprived of liberty, * patient with language issues (speaking or writing French)
Where it's running
-
Centre Hospital-Universitaire d'Amiens
Salouël, France Recruiting
Study contacts
- Study coordinator: Emmanuelle VERMES, MD
- Email: vermes.emmanuelle@chu-amiens.fr
- Phone: 33 + 322087302
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Severe Complications During VT/PVC Ablation
This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.
-
4D MRI parameters linked to cardiovascular and cancer disease outcomes
This study tests whether 4D MRI measurements can predict how cardiovascular diseases and cancer will progress in adults undergoing routine cardiac MRI at a single Korean hospital.
-
FAPI PET/CT imaging in arrhythmogenic right ventricular cardiomyopathy
This study will test whether a PET/CT scan using a 68Ga-DOTA-SA-FAPI tracer can detect active scarring in adults with ARVC and provide information beyond standard heart imaging.
-
Catheter ablation vs. anti-arrhythmic drugs for PVCs
This study tests whether catheter ablation or anti-arrhythmic medications are better at reducing PVC symptoms and improving quality of life for adults with a normal heart function.
-
Impact of Premature Ventricular Complexes on Respiratory and Physical Health
This study tests how premature ventricular complexes affect breathing, respiratory and hand strength, cough, physical activity, and quality of life in adults with PVCs compared with healthy controls.
-
Cardiac MRI blood-flow imaging to distinguish types of hypertrophic cardiomyopathy
We will try cardiac MRI perfusion imaging to see if blood-flow patterns can distinguish people with different forms of hypertrophic cardiomyopathy, including genetic carriers and related conditions like Fabry disease and cardiac amyloidosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.